甘肃医药
甘肅醫藥
감숙의약
Gansu Medical Journal
2014年
6期
416-417
,共2页
李野平%熊倩%李金菊%李国焕
李野平%熊倩%李金菊%李國煥
리야평%웅천%리금국%리국환
乙型肝炎%肝硬化%肝癌%性别%分布
乙型肝炎%肝硬化%肝癌%性彆%分佈
을형간염%간경화%간암%성별%분포
hepatitis B liver cirrhosis%hepatocellular carcinoma%gender distribution
目的:分析我院乙肝肝硬化和肝癌住院患者的性别分布情况。方法:回顾性分析2004~2013年我院住院的乙肝肝硬化和肝癌患者的性别分布情况。结果:共有384例乙肝肝硬化和肝癌患者住院;240例乙肝肝硬化患者中,男性为193例,女性为47例,男女之比为4.1:1;144例肝癌患者中,男性为129例,女性为15例,男女之比为8.6:1;两组患者的男女性别分布情况具有显著性差异(P<0.05)。结论:我院住院患者乙肝肝硬化和肝癌患者的性别分布情况为男多于女,在乙肝肝癌患者中更为显著。
目的:分析我院乙肝肝硬化和肝癌住院患者的性彆分佈情況。方法:迴顧性分析2004~2013年我院住院的乙肝肝硬化和肝癌患者的性彆分佈情況。結果:共有384例乙肝肝硬化和肝癌患者住院;240例乙肝肝硬化患者中,男性為193例,女性為47例,男女之比為4.1:1;144例肝癌患者中,男性為129例,女性為15例,男女之比為8.6:1;兩組患者的男女性彆分佈情況具有顯著性差異(P<0.05)。結論:我院住院患者乙肝肝硬化和肝癌患者的性彆分佈情況為男多于女,在乙肝肝癌患者中更為顯著。
목적:분석아원을간간경화화간암주원환자적성별분포정황。방법:회고성분석2004~2013년아원주원적을간간경화화간암환자적성별분포정황。결과:공유384례을간간경화화간암환자주원;240례을간간경화환자중,남성위193례,녀성위47례,남녀지비위4.1:1;144례간암환자중,남성위129례,녀성위15례,남녀지비위8.6:1;량조환자적남녀성별분포정황구유현저성차이(P<0.05)。결론:아원주원환자을간간경화화간암환자적성별분포정황위남다우녀,재을간간암환자중경위현저。
Objective: To analyse the gender distribution in hospitalized patients with hepatitis B liver cirrhosis and hepatocellular carcinoma in our hospital. Methods: The gender distribution was retrospectively analysed in hospitalized patients with hepatitis B liver cirrhosis and hepatocellular carcinoma in our hospital from 2004 to 2013. Results: There were a total of 384 hospitalized patients with hepatitis B liver cirrhosis and hepatocellular carcinoma in our hospital within ten years.240 cases were hepatitis B liver cirrhosis patients in which 193 cases were male patients, and 47 cases were female patients. The ratio of the male patients to female patients was 4.1:1. In 144 cases of hepatocellular carcinoma patients,129 cases were male patients,15 cases were female patients in which the ratio was 8.6:1. There was significant differences between male and female distribution of the two group (P<0.05). Conclusion: Male patients were more than female patients in ten years ’ hospitalized patients with hepatitis B liver cirrhosis and hepatocellular carcinoma in our hospital, especially in hepatocellular carcinoma patients.